These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27927781)

  • 21. Malic enzyme gene polymorphism is associated with responsiveness in circulating parathyroid hormone after long-term calcium supplementation.
    Chailurkit L; Chanprasertyothin S; Charoenkiatkul S; Krisnamara N; Rajatanavin R; Ongphiphadhanakul B
    J Nutr Health Aging; 2012 Mar; 16(3):246-51. PubMed ID: 22456781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations.
    Dastani Z; Berger C; Langsetmo L; Fu L; Wong BY; Malik S; Goltzman D; Cole DE; Richards JB
    J Bone Miner Res; 2014 Feb; 29(2):494-9. PubMed ID: 23857798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
    Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moderators of the Association Between Serum Parathyroid Hormone and Metabolic Syndrome in Participants with Elevated Parathyroid Hormone: NHANES 2003-2006.
    Chen L; Pei JH; Kuang J
    Horm Metab Res; 2020 Jul; 52(7):509-516. PubMed ID: 32325506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China.
    Zhang Q; Shi L; Peng N; Xu S; Zhang M; Zhang S; Li H; Zhuang H; Gong M; Wu D; Wang R
    Br J Nutr; 2016 Mar; 115(6):960-6. PubMed ID: 26843386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H; Khan AH; Riaz M; Karimi H; Talati J
    Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
    Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
    Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
    Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
    Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)
    Kritmetapak K; Losbanos L; Berent TE; Ashrafzadeh-Kian SL; Algeciras-Schimnich A; Hines JM; Singh RJ; Kumar R
    BMC Nephrol; 2021 Mar; 22(1):114. PubMed ID: 33784965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotypes in the CYP2R1 gene are associated with levels of 25(OH)D and bone mineral density, but not with other markers of bone metabolism (MrOS Sweden).
    Björk A; Mellström D; Ohlsson C; Karlsson M; Mallmin H; Johansson G; Ljunggren Ö; Kindmark A
    PLoS One; 2018; 13(12):e0209268. PubMed ID: 30576350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T; Ritz E; Passlick-Deetjen J
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of PTH (Parathyroid Hormone) Gene and Risk of Kidney Stone Disease: A Case-Control Study from West Bengal, India.
    Mitra P; Maity B; Pal DK; Das M
    Urology; 2018 Nov; 121():79-85. PubMed ID: 29969593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data mining: Biological and temporal factors associated with blood parathyroid hormone, vitamin D, and calcium concentrations in the Southwestern Chinese population.
    Ding F; Nie X; Li X; He Y; Li G
    Clin Biochem; 2021 Apr; 90():50-57. PubMed ID: 33539806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships with serum parathyroid hormone in old institutionalized subjects.
    Stein MS; Flicker L; Scherer SC; Paton LM; O'Brien ML; Walton SC; Chick P; Di Carlantonio M; Zajac JD; Wark JD
    Clin Endocrinol (Oxf); 2001 May; 54(5):583-92. PubMed ID: 11380488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
    Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
    Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
    Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
    Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.